Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus

Diabetes and Metabolism

Volumn 40, Issue 3, 2014, Pages 211-214

  Haidar, A ^a,c   Farid, D ^a,c   St Yves, A ^a   Messier, V ^a   Chen, V ^b   Xing, D ^b   Brazeau, A S ^a   Duval, C ^a   Boulet, B ^c   Legault, L ^d   Rabasa Lhoret, R ^a,e,f  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Montreal Diabetes Research Center   (Canada)

Author keywords

Artificial pancreas; Closed loop delivery; Glucagon; Postprandial control; Type 1 diabetes

Indexed keywords

CARBOHYDRATE; GLUCAGON; GLUCOSE; INSULIN ASPART; RECOMBINANT GLUCAGON; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; INSULIN;

AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CLINICAL ARTICLE; CLOSED LOOP GLUCOSE CONTROL; CONTROLLED STUDY; DRUG DELIVERY DEVICE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFUSION PUMP; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEAL; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SENSOR; ADULT; ALGORITHM; ARTIFICIAL PANCREAS; CANADA; CARBOHYDRATE DIET; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION; METABOLISM; TREATMENT OUTCOME;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BREAKFAST; CANADA; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PANCREAS, ARTIFICIAL; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84902550021     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.12.001     Document Type: Article

References (14)

1. Hovorka R. Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol 2011, 7:385-395.
2. Hovorka R., Kumareswaran K., Harris J., Allen J.M., Elleri D., Xing D., et al. Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011, 342:d1855.
3. Haidar A., Legault L., Dallaire M., Alkhateeb A., Coriati A., Messier V., et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ 2013, 185:297-305.
4. Elleri D., Allen J.M., Kumareswaran K., Leelarathna L., Nodale M., Caldwell K., et al. Closed-loop basal insulin delivery over 36hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013, 36:838-844.
5. Weinzimer S.A., Steil G.M., Swan K.L., Dziura J., Kurtz N., Tamborlane W.V. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008, 31:934-939.
6. El-Khatib F.H., Russell S.J., Nathan D.M., Sutherlin R.G., Damiano E.R. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010, 2:27ra.
7. Haidar A., Elleri D., Kumareswaran K., Leelarathna L., Allen J.M., Caldwell K., et al. Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility, and effect of age, weight and duration of diabetes. Diabetes Care 2013, Accepted.
8. Castle J.R., Engle J.M., El Youssef J., Massoud R.G., Ward W.K. Factors influencing the effectiveness of glucagon for preventing hypoglycaemia. J Diabet Sci Technol 2010, 4:1305-1310.
9. Russell S.J., El-Khatib F.H., Nathan D.M., Damiano E.R. Efficacy determinants of subcutaneous microdose glucagon during closed-loop control. J Diabet Sci Technol 2010, 4:1288-1304.
10. Hinshaw L., Dalla Man C., Nandy D.K., Saad A., Bharucha A.E., Levine J.A., et al. Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 2013, 62:2223-2229.
11. Mathiesen E.R., Rubin P., Sandahl Christiansen J., Aaby Svendsen P., Lauritzen T., Deckert T. Diurnal pattern of insulin requirements in insulin-dependent diabetics. Scand J Clin Lab Invest 1982, 42:63-68.
12. Scavone G., Manto A., Pitocco D., Gagliardi L., Caputo S., Mancini L., et al. Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study. Diabet Med 2010, 27:477-479.
13. Mehta S.N., Quinn N., Volkening L.K., Laffel L.M. Impact of carbohydrate counting on glycaemic control in children with type 1 diabetes. Diabetes Care 2009, 32:1014-1016.
14. Brazeau A.S., Mircescu H., Desjardins K., Leroux C., Strychar I., Ekoe J.M., et al. Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes. Diabetes Res Clin Pr 2013, 99:19-23.